Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Lung Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 5Carboplatin 5Docetaxel 4Cisplatin 4Bevacizumab 4Taxes 3Drug Therapy 3Gemcitabine 2Fluorodeoxyglucose F18 2Cetuximab 2saracatinib 1endostar protein 1cediranib 1aflutinib 1Zoledronic Acid 1X-Rays 1Vinorelbine 1Thoracic Surgery, Video-Assisted 1Spectrum Analysis 1Silver Nitrate 1Saline Solution 1Radiotherapy, Conformal 1Radiation 1Pleurodesis 1Pemetrexed 1Nivolumab 1Naproxen 1N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1Morphine 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pleural Effusion, Malignant × Naproxen × Clear all
NCT01612975 2018-02-15

The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection

McMaster University

Phase 2 Terminated
7 enrolled
Thoracic

Lung Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡